Poster - Thurs Eve-05: An assessment of PDDs and outputs predicted by a Monte Carlo-based treatment planning system for electron beams

2008 ◽  
Vol 35 (7Part2) ◽  
pp. 3402-3402
Author(s):  
I AlDahlawi ◽  
M Evans ◽  
B Reniers ◽  
K Asiev ◽  
J Last ◽  
...  
Keyword(s):  
Monte Carlo ◽  
Treatment Planning ◽  
Electron Beams ◽  
Planning System ◽  
Treatment Planning System

Clinical use of a commercial Monte Carlo treatment planning system for electron beams

2005 ◽  
Vol 50 (5) ◽  
pp. 1029-1034 ◽  
Author(s):  
J E Cygler ◽  
C Lochrin ◽  
G M Daskalov ◽  
M Howard ◽  
R Zohr ◽  
...  
Keyword(s):  
Monte Carlo ◽  
Treatment Planning ◽  
Electron Beams ◽  
Planning System ◽  
Treatment Planning System ◽  
Clinical Use

scholarly journals A benchmarking method to evaluate the accuracy of a commercial proton monte carlo pencil beam scanning treatment planning system

2017 ◽  
Vol 18 (2) ◽  
pp. 44-49 ◽  
Author(s):  
Liyong Lin ◽  
Sheng Huang ◽  
Minglei Kang ◽  
Petri Hiltunen ◽  
Reynald Vanderstraeten ◽  
...  
Keyword(s):  
Monte Carlo ◽  
Treatment Planning ◽  
Planning System ◽  
Treatment Planning System ◽  
Pencil Beam ◽  
Beam Scanning ◽  
Pencil Beam Scanning

scholarly journals Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Naonori Hu ◽  
Hiroki Tanaka ◽  
Ryo Kakino ◽  
Syuushi Yoshikawa ◽  
Mamoru Miyao ◽  
...  
Keyword(s):  
Monte Carlo ◽  
Treatment Planning ◽  
Neutron Capture ◽  
Gamma Ray ◽  
Dose Calculation ◽  
Planning System ◽  
Treatment Planning System ◽  
Neutron Capture Therapy ◽  
Boron Neutron Capture ◽  
Monte Carlo Dose Calculation

AbstractBoron neutron capture therapy (BNCT) for the treatment of unresectable, locally advanced, and recurrent carcinoma of the head and neck cancer has been approved by the Japanese government for reimbursement under the national health insurance as of June 2020. A new treatment planning system for clinical BNCT has been developed by Sumitomo Heavy Industries, Ltd. (Sumitomo), NeuCure® Dose Engine. To safely implement this system for clinical use, the simulated neutron flux and gamma ray dose rate inside a water phantom was compared against experimental measurements. Furthermore, to validate and verify the new planning system, the dose distribution inside an anthropomorphic head phantom was compared against a BNCT treatment planning system SERA and an in-house developed Monte Carlo dose calculation program. The simulated results closely matched the experimental results, within 5% for the thermal neutron flux and 10% for the gamma ray dose rate. The dose distribution inside the head phantom closely matched with SERA and the in-house developed dose calculation program, within 3% for the tumour and a difference of 0.3 Gyw for the brain.

Sign in / Sign up

Export Citation Format

Share Document